August 31, 2017

WHO Prequalifies Childhood TB Medicine

TB Alliance led efforts to develop improved medicines for children with tuberculosis
June 22, 2017

An Open Letter to Dr. Tedros

TB Alliance Congratulates New WHO Director-General
May 11, 2017

EU Leaders Urge Funding of Critically-needed New Tools against Drug-resistant Tuberculosis

Participants at high-level meeting seek to end TB health threat in Europe
March 24, 2017

TB Alliance Sublicenses Promising Anti-Tuberculosis Drug from the Medicines Patent Pool

Agreement announced on World Tuberculosis Day revitalizes efforts to develop sutezolid as effective response to infectious disease killer
February 28, 2017

TB Alliance Calls on WHO to Add TB to List of Bacteria in Critical Need of Antibiotics

First-ever list of antibiotic-resistant "priority pathogens" excludes mycobacterium tuberculosis
January 20, 2017

Médecins Sans Frontières Partners with TB Alliance in Three-Country Study

Study builds on promising results from TB Alliance’s late-stage trials
December 16, 2016

Clinical Trial of BPaMZ Regimen Will Replace Phase 3 STAND Trial

STAND trial will not re-open patient enrollment
October 27, 2016

TB Alliance partners with PepsiCo to advance the fight for improved medicines for children

Leveraging shared expertise to help eliminate unpleasant taste of TB medicines to improve palatability and treatment for children with TB

Pages